| BRIGHTOUTCOME INC | US | unknown | $2.5M |
| Cadrenal Therapeutics, Inc. | US | unknown | $4.4M |
| Cancer Targeted Technology LLC | US | unknown | $2.0M |
| Candor | US | seed | $1.0M |
| Caris Life Sciences | US | series-b+ | $1.2B |
| CellCentric | GB | series-b+ | $300.0M |
| CELLCHORUS INC | US | unknown | $2.0M |
| CELLIBRE, INC. | US | unknown | $2.0M |
| Cellphire, Inc | US | unknown | $3.0M |
| Cellular Origins | GB | series-a | $36.7M |
| Cementic | FR | seed | $4.3M |
| Chai Discovery | US | series-b+ | $200.0M |
| Chai Discovery | US | series-b+ | $225.0M |
| Chemify | GB | series-a | $46.4M |
| Chronicle Bio, Inc. | US | unknown | $2.2M |
| CIVATECH ONCOLOGY, INC. | US | unknown | $4.0M |
| Climb Bio, Inc. | US | unknown | $110.1M |
| COG ANALYTICS, LLC | US | unknown | $1.9M |
| Cognito Therapeutics | US | series-b+ | $314.5M |
| COLLAGEN MEDICAL LLC | US | unknown | $2.0M |
| COLLAMEDIX INC | US | unknown | $2.0M |
| COLLINGE AND ASSOCIATES, INC. | US | unknown | $2.0M |
| Colossal Biosciences | US | series-b+ | $567.7M |
| Conductor Quantum | US | seed | $1.0M |
| Consano Bio, Inc. | US | unknown | $34.8M |
| CONSEGNA PHARMA INC | US | unknown | $2.5M |
| Continuity Biosciences | US | unknown | $3.0M |
| Converge Bio | US | series-a | $30.0M |
| Corvia Medical, Inc | US | unknown | $8.9M |
| Cradle | CH | series-b+ | $103.0M |
| CREARE LLC | US | unknown | $2.3M |
| CroBio | GB | seed | $3.0M |
| Crossbow Therapeutics | US | series-b+ | $120.0M |
| Crossbow Therapeutics | US | series-b+ | $77.0M |
| Crossbow Therapeutics | US | series-b+ | $198.0M |
| CROSSLIFE TECHNOLOGIES INC. | US | unknown | $2.0M |
| Crystalys Therapeutics | US | series-a | $250.0M |
| Cure51 | FR | seed | $16.2M |
| Cutiss | CH | series-b+ | $61.6M |
| Cyclana Bio | GB | seed | $6.3M |
| Cyclana Bio | GB | pre-seed | $6.0M |
| Cyrus Biotechnology, Inc. | US | unknown | $3.2M |
| Cyted Health | GB | series-b+ | $100.0M |
| Cytely | SE | seed | $3.2M |
| Cytoagents, Inc. | US | unknown | $2.0M |
| CYTONUS THERAPEUTICS INC | US | unknown | $2.0M |
| Dalan Bio | ES | seed | $3.0M |
| DARE BIOSCIENCE, INC. | US | unknown | $2.0M |
| Dash Bio, Inc | US | unknown | $11.0M |
| Dash Bio, Inc. | US | unknown | $11.0M |
| Devorto Corporation | US | unknown | $1.9M |
| DMC Biotechnologies, Inc | US | unknown | $1.4M |
| DOSEOPTICS LLC | US | unknown | $2.0M |
| Draupnir Bio | DK | seed | $13.0M |
| ECLIPSE ORTHOPAEDICS, LLC | US | unknown | $2.0M |
| EG 427 | FR | series-b+ | $43.2M |
| Electra Therapeutics | US | series-b+ | $300.0M |
| Elkedonia | FR | seed | $12.2M |
| EMMUNE INC | US | unknown | $3.0M |
| Emmyon, INC. | US | series-b+ | $3.0M |
| EMOCHA MOBILE HEALTH INC. | US | unknown | $2.0M |
| EMPOWERX, INC. | US | unknown | $1.9M |
| Enable Biosciences Inc. | US | unknown | $2.9M |
| ENALARE THERAPEUTICS INC | US | unknown | $2.5M |
| ENDOTHEIA INC | US | unknown | $2.0M |
| Enifer | FI | series-b+ | $38.9M |
| EnsiliTech | GB | seed | $5.6M |
| Enveda | US | series-b+ | $350.0M |
| EPICYPHER, INC. | US | unknown | $3.0M |
| EPIGEN BIOSCIENCES INC | US | unknown | $2.0M |
| Epigenica | SE | seed | $1.9M |
| EPIGENOME TECHNOLOGIES, INC. | US | unknown | $2.0M |
| EtiraRX, Inc. | US | unknown | $2.3M |
| EVERGLADES BIOPHARMA LLC | US | unknown | $2.0M |
| EvlaBio | CH | seed | $27.0M |
| EVODENOVO INC | US | unknown | $2.0M |
| EvodiaBio | DK | series-a | $14.0M |
| EVOQ THERAPEUTICS, INC. | US | unknown | $2.0M |
| EXAVIR THERAPEUTICS INC. | US | unknown | $3.0M |
| Exciva | DE | series-b+ | $55.1M |
| EXTEND BIOSCIENCES INC | US | unknown | $2.0M |
| Extend Biosciences INC | US | series-b+ | $2.0M |
| Fasal Bio | HR | series-a | $7.6M |
| Fathom Therapeutics | US | series-a | $65.0M |
| Fathom Therapeutics | US | series-a | $47.0M |
| Federated Biologics | US | unknown | $6.0M |
| FERROSA | CH | seed | $3.5M |
| FESARIUSTHERAPEUTICS INC | US | unknown | $1.9M |
| FinalDose | GB | seed | $1.0M |
| Florey Biosciences, Inc. | US | unknown | $1.4M |
| FoRx Therapeutics | CH | series-a | $46.1M |
| FOX CHASE CHEMICAL DIVERSITY CENTER INC. | US | unknown | $2.0M |
| FRAMESHIFT LABS INC | US | unknown | $2.0M |
| Freya Biosciences | DK | series-a | $30.0M |
| GENNEXT TECHNOLOGIES, INC. | US | unknown | $2.5M |
| GlycoEra | CH | series-b+ | $130.0M |
| GLYCOMANTRA INC | US | unknown | $3.7M |
| GLYTR THERAPEUTICS, INC. | US | unknown | $2.0M |
| GODX INC | US | unknown | $2.0M |
| GRANATA BIO Corp | US | unknown | $13.8M |